Skip to main content
. 2016 Aug 17;11(8):e0160971. doi: 10.1371/journal.pone.0160971

Fig 3.

Fig 3

Use of a) NPH insulin, b) long-acting insulin analogues, c) rapid-acting insulin analogues, and d) SMBG per day in pediatric patients with type 1 diabetes, stratified by calendar year and age-groups. Data adjusted for sex, diabetes duration, and migratory background.